Skip to main content
. 2020 Nov 25;2020:1392674. doi: 10.1155/2020/1392674

Figure 1.

Figure 1

Association with LYNX1 expression and clinicopathological characteristics including (a) clinical stage, primary therapy outcome (b), cancer status (c), histologic grade (d), tumor residual disease (e), and anatomic neoplasm subdivision (f) in patients with ovarian serous cystadenocarcinoma (OVs) in The Cancer Genome Atlas (TCGA) cohort.